What are the best treatments for Best Vitelliform Macular Dystrophy?

Currently, there is no curative treatment for Best Vitelliform Macular Dystrophy, so management focuses on monitoring for complications and maximizing remaining vision. While most patients maintain good central vision for many years, treatment is primarily supportive and personalized based on the specific stage of the disease and the presence of secondary complications.

How is Best Vitelliform Macular Dystrophy managed clinically?

Management of Best Vitelliform Macular Dystrophy centers on regular ophthalmic surveillance to detect the development of choroidal neovascularization (CNV), a complication that can lead to rapid vision loss. Because the disease progression varies significantly between individuals—even within the same family—treatment is tailored to the patient’s specific ocular health and visual needs.

What treatments are used if complications occur?

If Best Vitelliform Macular Dystrophy leads to the growth of abnormal blood vessels (CNV), ophthalmologists may utilize the following interventions:

• Anti-VEGF injections: Medications such as ranibizumab (Lucentis) or aflibercept (Eylea) are often used to address macular edema or neovascularization.


• Photodynamic therapy (PDT): A laser-based treatment sometimes utilized in specific cases of neovascularization.


• Low vision aids: Occupational therapy and specialized optical devices help patients adapt to central vision changes.


• Lifestyle modifications: Wearing UV-blocking sunglasses is often recommended to protect the retina from potential light-induced stress.

Which specialists should be on the care team?

A multidisciplinary approach is essential for patients with Best Vitelliform Macular Dystrophy. Your care team should ideally include a retina specialist (ophthalmologist), a low-vision optometrist, and a genetic counselor to discuss the autosomal dominant inheritance pattern of the condition. At DiseaseMaps.org, 6 community members are currently sharing their experiences with Best Vitelliform Macular Dystrophy, which can be a valuable resource for finding peer support.

Are there emerging treatments for Best Vitelliform Macular Dystrophy?

Research into gene therapy and neuroprotective agents for Best Vitelliform Macular Dystrophy is ongoing. Clinical trials are the best way to gain access to cutting-edge research, though currently, no gene-editing therapy has been approved for standard clinical use. Patients are encouraged to monitor sites like ClinicalTrials.gov for updates regarding BEST1-related retinal dystrophies.

Next steps

• Schedule a comprehensive dilated eye exam with a retina specialist.


• Connect with the Best Vitelliform Macular Dystrophy community on DiseaseMaps.org to share experiences.


• Consult with a genetic counselor to understand the implications for family members.


• Inquire about low-vision rehabilitation services to optimize daily functioning.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult your healthcare provider for personalized diagnosis and treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Best Vitelliform Macular Dystrophy.


• Orphanet: Best disease (ORPHA:125).


• OMIM (Online Mendelian Inheritance in Man): #153700 (Bestrophinopathy).


• American Academy of Ophthalmology (AAO) EyeWiki: Best Vitelliform Macular Dystrophy.